← Back to headlines
FDA Considers Staff Bonuses to Expedite Drug Reviews
The FDA is reportedly exploring the use of staff bonuses as a mechanism to accelerate the review process for new drugs.
26 Feb, 18:35 — 26 Feb, 18:35
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Doctors’ goal: Zero dengue deaths by year 2030
just now
Philippine DOH Clarifies No Penalties for Parents Refusing Child Vaccination
just now
Research Finds Lower Life Expectancy and Income for Visually Impaired Kiwis
9m ago
Lupita Nyong’o Reveals Return of Uterine Fibroids, Calls for Improved Treatment
14m ago